Elisabetta Pennacchioli Selected Research

Elisabetta Pennacchioli Research Topics

Disease

20	Neoplasms (Cancer) 03/2024 - 04/2005
10	Melanoma (Melanoma, Malignant) 02/2022 - 04/2005
5	Sarcoma (Soft Tissue Sarcoma) 03/2024 - 12/2010
4	Neoplasm Metastasis (Metastasis) 01/2022 - 06/2007
3	Hyperthermia 03/2024 - 09/2002
3	Carcinoma (Carcinomatosis) 01/2020 - 09/2002
2	Hemangiosarcoma (Angiosarcoma) 05/2023 - 01/2022
2	Leiomyosarcoma 01/2023 - 12/2010
2	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 01/2023 - 12/2010
2	Merkel Cell Carcinoma 04/2021 - 01/2020
1	Necrosis 03/2024
1	Breast Neoplasms (Breast Cancer) 12/2021
1	Pancreatic Neoplasms (Pancreatic Cancer) 10/2021
1	Neurofibrosarcoma (MPNST) 06/2021
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2020
1	Lymphatic Metastasis 01/2020
1	Lung Neoplasms (Lung Cancer) 01/2019
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2019
1	Skin Neoplasms (Skin Cancer) 02/2018
1	Nevus (Nevi) 09/2014
1	Hypopigmentation (Hypomelanosis) 09/2014
1	Pigmented Nevus (Melanocytic Nevus) 09/2014
1	Condylomata Acuminata (Genital Wart) 09/2014
1	Vitiligo 09/2014
1	Renal Cell Carcinoma (Grawitz Tumor) 07/2014
1	Circulating Neoplastic Cells 10/2012
1	Retroperitoneal liposarcoma 12/2010
1	Testicular Neoplasms (Testicular Cancer) 01/2009
1	Second Primary Neoplasms (Neoplasms, Second) 01/2009
1	Mesothelioma 07/2003
1	Ascites 09/2002
1	Mucinous Adenocarcinoma (Mucinous Carcinoma) 09/2002
1	Rare Diseases (Rare Disease) 09/2002
1	Pseudomyxoma Peritonei 09/2002

Drug/Important Bio-Agent (IBA)

3	Heat-Shock Proteins (Heat-Shock Protein)IBA 07/2014 - 08/2006
3	Peptides (Polypeptides)IBA 07/2014 - 05/2006
2	Imatinib Mesylate (Gleevec)FDA Link 01/2023 - 12/2010
2	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 10/2012
2	Dihydrotachysterol (AT 10)IBA 01/2022 - 06/2007
2	Biomarkers (Surrogate Marker)IBA 12/2021 - 10/2012
2	VaccinesIBA 07/2014 - 08/2006
2	AntigensIBA 08/2006 - 05/2006
1	CytokinesIBA 03/2024
1	NucleotidesIBA 01/2023
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2023
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2023
1	Protein Isoforms (Isoforms)IBA 01/2023
1	Cholecalciferol (Vitamin D3)FDA Link 06/2021
1	Vitamin D FDA LinkGeneric 06/2021
1	Complement System Proteins (Complement)IBA 01/2021
1	Keratins (Keratin)IBA 01/2021
1	Propranolol (Inderal)FDA LinkGeneric 02/2018
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 02/2018
1	Imiquimod (Aldara)FDA LinkGeneric 09/2014
1	Immunomodulating AgentsIBA 07/2014
1	AntibodiesIBA 10/2013
1	IpilimumabIBA 10/2013
1	ChemokinesIBA 10/2012
1	MicroRNAs (MicroRNA)IBA 10/2012
1	Proteins (Proteins, Gene)FDA Link 10/2012
1	Alkylating AgentsIBA 02/2009
1	PlatinumIBA 02/2009
1	Tumor Biomarkers (Tumor Markers)IBA 01/2009
1	vitespinIBA 08/2006
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 08/2006
1	EnzymesIBA 08/2006
1	Interferon-alpha (Interferon Alfa)IBA 08/2006
1	MART-1 AntigenIBA 05/2006
1	Chemokine CCL21IBA 04/2005
1	Lymphotoxin beta ReceptorIBA 04/2005
1	LigandsIBA 04/2005
1	Interleukin-2 (IL2)IBA 04/2005
1	Member 14 Tumor Necrosis Factor ReceptorsIBA 04/2005
1	MucinsIBA 09/2002

Therapy/Procedure

9	Drug Therapy (Chemotherapy) 03/2024 - 01/2009
5	Immunotherapy 02/2022 - 10/2013
5	Therapeutics 01/2022 - 01/2009
3	Pancreatectomy 03/2022 - 03/2011
3	Radiotherapy 04/2021 - 06/2007
2	Lymph Node Excision (Lymph Node Dissection) 01/2022 - 01/2020
2	Surgical Amputation (Amputations) 06/2021 - 12/2007
2	Cytoreduction Surgical Procedures 07/2003 - 09/2002
1	Operative Surgical Procedures 03/2024
1	Mastectomy (Mammectomy) 11/2023
1	Segmental Mastectomy (Lumpectomy) 11/2023
1	Adjuvant Chemotherapy 01/2022
1	Brachytherapy 06/2021
1	Off-Label Use 02/2018
1	Photochemotherapy (Photodynamic Therapy) 02/2018
1	Molecular Targeted Therapy 12/2010
1	Hyperthermic Intraperitoneal Chemotherapy 12/2010
1	Combined Modality Therapy 02/2009
1	Induction Chemotherapy 07/2003